- Scientists have classified covid infected people into different types based on risk factors and severity of the disease.
- 3 phenotypes have been underlined based on comorbidities like heart and kidney problems, respiratory ailments, etc
- Type I had heart and kidney issues while type III had respiratory issues
- Type III require hospitalizations whereas Type I faces severe clinical outcomes
- Type I & II face greater health hazard than Type III
- This study has opened up avenues for phenotype-specific treatments.
According to a report published by Wired Science, scientists have identified three different types of COVID-19 disease traits in patients, depending on their comorbidities, complications, and clinical outcomes, an advance that may help target future interventions to the most risk-prone individuals.
The Different Phenotypes & Severity of COVID
The new study, published in the journal PLOS ONE, analyzed the electronic health records (EHRs) from 14 hospitals in the midwestern US and from 60 primary care clinics in the state of Minnesota.
According to the researchers, including those from the University of Minnesota in the US, the study included 7,538 patients with confirmed COVID-19 between March 7 and August 25, 2020, of which 1,022 patients required hospitalization.
- Phenotype II, Mild Infection
Close to 60% of the patients included in the research presented with what the researchers called “phenotype II.”
2. The Adverse Phenotype or Phenotype I
They said about 23% of the patients presented with “phenotype I,” or the “adverse phenotype,” which was associated with the worst clinical outcomes.
The researchers said these patients had the highest level of comorbidities related to heart and kidney dysfunction.
3. Favorable Phenotype of Phenotype III
According to the study, 173 patients, or 16.9%, presented with “phenotype III” or the “favourable phenotype,” which the scientists said was associated with the best clinical outcomes.
While this group had the lowest complication rate and mortality, the scientists said these patients had the highest rate of respiratory comorbidities as well as a 10 percent greater risk of hospital readmission compared to the other phenotypes.
Overall, they said phenotypes I and II were associated with 7.30-fold and 2.57-fold increases in hazard of death relative to phenotype III.
Phenotype Specific Medical Care Needed
Based on the results, the scientists said such phenotype-specific medical care could improve COVID-19 outcomes.
However, they believe further studies are needed to determine the utility of these findings in clinical practice.
“Patients do not suffer from COVID-19 in a uniform matter. By identifying similarly affected groups, we not only improve our understanding of the disease process, but this enables us to precisely target future interventions to the highest risk patients,” the scientists added.
Did you subscribe to our daily newsletter?
It’s Free! Click here to Subscribe!
Source: Wire Science
